See also this year's filing and all EDGAR filings for this company.
PDF Report 0001567514_2023_Intra_Cellular_Therapies_Inc.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001567514, Intra-Cellular Therapies Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 737,957,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,913,000 |
| 3 | remainder_Assets | 14,910,000 |
| 4 | LiabilitiesCurrent | 83,236,000 |
| 5 | LiabilitiesNoncurrent | 15,474,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 358,782,000 |
| 9 | ResearchAndDevelopmentExpense | 134,715,000 |
| 10 | remainder_Expenses | 20,449,000 |
| 11 | remainder_Revenues | 250,314,000 |
| 12 | remainder_NetIncome | 7,376,000 |
| 13 | remainder_ComprehensiveNetIncome | -3,826,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 754,780,000 |
| 1 | Liabilities | 98,710,000 |
| 2 | Expenses | 513,946,000 |
| 3 | Revenues | 250,314,000 |
| 4 | StockholdersEquity | 656,070,000 |
| 5 | NetIncome | -256,256,000 |
| 6 | ComprehensiveNetIncome | -258,169,000 |
| 7 | BaseVar | 814,476,000 |
| 8 | EconomicCapitalRatio | 2.04 |